218 related articles for article (PubMed ID: 22449929)
1. Lipid nanoparticles for drug targeting to the brain.
Bondì ML; Di Gesù R; Craparo EF
Methods Enzymol; 2012; 508():229-51. PubMed ID: 22449929
[TBL] [Abstract][Full Text] [Related]
2. Solid lipid nanoparticles for targeted brain drug delivery.
Blasi P; Giovagnoli S; Schoubben A; Ricci M; Rossi C
Adv Drug Deliv Rev; 2007 Jul; 59(6):454-77. PubMed ID: 17570559
[TBL] [Abstract][Full Text] [Related]
3. Solid lipid nanoparticles as a drug delivery system for peptides and proteins.
Almeida AJ; Souto E
Adv Drug Deliv Rev; 2007 Jul; 59(6):478-90. PubMed ID: 17543416
[TBL] [Abstract][Full Text] [Related]
4. Lipid nanoparticles: effect on bioavailability and pharmacokinetic changes.
Souto EB; Müller RH
Handb Exp Pharmacol; 2010; (197):115-41. PubMed ID: 20217528
[TBL] [Abstract][Full Text] [Related]
5. Chapter 6 - Solid lipid nanoparticle formulations pharmacokinetic and biopharmaceutical aspects in drug delivery.
Souto EB; Doktorovová S
Methods Enzymol; 2009; 464():105-29. PubMed ID: 19903552
[TBL] [Abstract][Full Text] [Related]
6. Lipid nanoparticles for parenteral delivery of actives.
Joshi MD; Müller RH
Eur J Pharm Biopharm; 2009 Feb; 71(2):161-72. PubMed ID: 18824097
[TBL] [Abstract][Full Text] [Related]
7. High melting lipid based approach for drug delivery: solid lipid nanoparticles.
Kumar S; Randhawa JK
Mater Sci Eng C Mater Biol Appl; 2013 May; 33(4):1842-52. PubMed ID: 23498204
[TBL] [Abstract][Full Text] [Related]
8. Chapter 1 - Drug delivery to the brain using colloidal carriers.
Chang J; Jallouli Y; Barras A; Dupont N; Betbeder D
Prog Brain Res; 2009; 180():2-17. PubMed ID: 20302826
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticulate devices for brain drug delivery.
Celia C; Cosco D; Paolino D; Fresta M
Med Res Rev; 2011 Sep; 31(5):716-56. PubMed ID: 20162690
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid nanoparticles as drug delivery systems.
Manjunath K; Reddy JS; Venkateswarlu V
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):127-44. PubMed ID: 15834465
[TBL] [Abstract][Full Text] [Related]
11. Potential of solid lipid nanoparticles in brain targeting.
Kaur IP; Bhandari R; Bhandari S; Kakkar V
J Control Release; 2008 Apr; 127(2):97-109. PubMed ID: 18313785
[TBL] [Abstract][Full Text] [Related]
12. Solid lipid nanoparticles as vehicles of drugs to the brain: current state of the art.
Gastaldi L; Battaglia L; Peira E; Chirio D; Muntoni E; Solazzi I; Gallarate M; Dosio F
Eur J Pharm Biopharm; 2014 Aug; 87(3):433-44. PubMed ID: 24833004
[TBL] [Abstract][Full Text] [Related]
13. Brain-targeted solid lipid nanoparticles containing riluzole: preparation, characterization and biodistribution.
Bondì ML; Craparo EF; Giammona G; Drago F
Nanomedicine (Lond); 2010 Jan; 5(1):25-32. PubMed ID: 20025461
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of lipid nanoparticles for camptothecin delivery: a comparison of solid lipid nanoparticles, nanostructured lipid carriers, and lipid emulsion.
Huang ZR; Hua SC; Yang YL; Fang JY
Acta Pharmacol Sin; 2008 Sep; 29(9):1094-102. PubMed ID: 18718178
[TBL] [Abstract][Full Text] [Related]
15. Brain targeting of risperidone-loaded solid lipid nanoparticles by intranasal route.
Patel S; Chavhan S; Soni H; Babbar AK; Mathur R; Mishra AK; Sawant K
J Drug Target; 2011 Jul; 19(6):468-74. PubMed ID: 20958095
[TBL] [Abstract][Full Text] [Related]
16. Nanostructure-based drug delivery systems for brain targeting.
Haque S; Md S; Alam MI; Sahni JK; Ali J; Baboota S
Drug Dev Ind Pharm; 2012 Apr; 38(4):387-411. PubMed ID: 21954902
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY
Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498
[TBL] [Abstract][Full Text] [Related]
18. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
19. Formulation development and systematic optimization of solid lipid nanoparticles of quercetin for improved brain delivery.
Dhawan S; Kapil R; Singh B
J Pharm Pharmacol; 2011 Mar; 63(3):342-51. PubMed ID: 21749381
[TBL] [Abstract][Full Text] [Related]
20. Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release.
Souza LG; Silva EJ; Martins AL; Mota MF; Braga RC; Lima EM; Valadares MC; Taveira SF; Marreto RN
Eur J Pharm Biopharm; 2011 Sep; 79(1):189-96. PubMed ID: 21352915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
